Navigation Links
US Senate Approves Embryo-research Plan Despite President's Refusal

The US Senate voted to expand federal funding for research on new human embryonic stem cells, setting the stage for George W. Bush's first veto of his presidency.//

The 63-37 vote followed two days of debate that pitted the promise of new disease cures against deep questions of conscience, especially among Bush's supporters on the religious right who view embryos as human life and oppose the measure.

Tuesday's vote was coloured by election-year politics and personal views that cut across party lines. The House of Representatives - Republican-controlled, like the Senate - had passed the bill last year.

White House spokesman Tony Snow reiterated before the vote that Bush would veto the measure.

"The president believes strongly that for the purpose of research it's inappropriate for the federal government to finance something that many people consider murder. He's one of them," Snow said.

The measure would lift restrictions Bush imposed in August 2001 on the grounds that the research destroys human embryos.

Scientists, eager to explore the potential for treating brain diseases such as Alzheimer's and diabetes, have pressed the government to ease the restrictions.

So has Senate Republican majority leader Bill Frist, a key White House ally in Congress who broke with Bush over stem-cell research last year.

Others who appealed to Bush to change his mind included former first lady Nancy Reagan, whose late husband Ronald Reagan suffered from Alzheimer's, and California Governor Arnold Schwarzenegger.

Frist, a medical doctor, argued Monday that the limitations will "slow our ability to bring potential new treatments for certain diseases."

Bush in 2001 limited federal research to 78 stem-cell lines derived from fertilized human eggs. Creating new lines would have involved the destruction of human embryos.

The government has since admitted that man y of the cell lines are contaminated, cutting the useable number to 22.

With polls showing most Americans support stem-cell research, opposition Democrats are seeking to capitalise on the issue in campaigning for mid-term Congressional elections in November.

But it appears unlikely that the 100-member Senate would muster the needed 67 votes to override a presidential veto.

(Source: IANS)

Related medicine news :

1. Senate assures ban on smoking
2. US Senate Votes against Testing of Pesticide on Humans
3. Senate Committee Approves Telemedicine Mental Health Bill
4. US Senate Passes Stem Cell Research Bill
5. FDA Approves Contraceptive Ring
6. FDA Approves New HIV Drug, Viread
7. FDA Approves Birth Control Skin Patch
8. FDA Approves New Arthritis Drug, Bextra
9. FDA Approves Elidel Cream for Eczema
10. FDA Approves New Anti-Clotting Drug
11. FDA Approves New surgery Treatment for Farsightedness
Post Your Comments:

(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... December 1, 2015 --> ... research report "Nucleic Acid Labeling Market by Product (Reagents ... Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), ... MarketsandMarkets, The global market is expected to reach USD ... 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
Breaking Medicine Technology: